Skip to the page

Data / Drug companies / Imiquimod

Imiquimod: 10 companies and 14 products in the FDA NDC directory

Imiquimod is listed in the FDA National Drug Code Directory by 10 companies, with 14 products in commercial distribution. 9 of the products (64.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are cream, and the newest product started marketing on September 1, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
10
Products
14
Generic (ANDA) products
9 (64.3%)
Application numbers
5
Routes
Topical
Brand names
Zyclara
openFDA record search
api.fda.gov

Companies that list imiquimod

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Bausch Health US, LLC3creamNew drug applications (NDA)February 29, 2012
Bryant Ranch Prepack2creamGeneric drugs (ANDA)November 9, 2010
Sun Pharmaceutical Industries, Inc.2creamGeneric drugs (ANDA)January 26, 2021
Anvi Pharmaceuticals Inc1creamGeneric drugs (ANDA)September 1, 2026
Bryant Ranch Prepack1creamGeneric drugs (ANDA)November 9, 2010
Direct_Rx1creamGeneric drugs (ANDA)March 23, 2020
Glenmark Pharmaceuticals Inc., USA1creamGeneric drugs (ANDA)March 6, 2012
Oceanside Pharmaceuticals1creamNew drug applications (NDA)June 27, 2018
Padagis Israel Pharmaceuticals Ltd1creamGeneric drugs (ANDA)November 9, 2010
Teva Pharmaceuticals USA, Inc.1creamAuthorized generics (NDA)July 30, 2020

Dosage forms

Dosage formProductsShare
Cream14100%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)964.3%
New drug applications (NDA)428.6%
Authorized generics (NDA)17.1%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.